Firdapse (amifampridine) / BioMarin, Catalyst Pharma  >>  Phase 2
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Firdapse (amifampridine) / BioMarin, Catalyst Pharma
2015-003127-62: A Randomized, Placebo-Controlled Study to Evaluate the Effect of Amifampridine in Patients with MuSK Antibody Positive Myasthenia Gravis Studio randomizzato controllato con placebo per valutare l'effetto dell'amifampridina in pazienti affetti da Miastenia Grave Musk positivi

Checkmark Topline data for MuSK antibody positive myasthenia gravis
Ongoing
2
20
Europe
AMIFAMPRIDINA, Tablet, FIRDAPSE - 10 MG - COMPRESSE - USO ORALE - BLISTER(ALU/PVC/PVDC) 100 X 1 COMPRESSE
FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA, Catalyst Pharmaceutical Partners, Inc.
Patients with MuSK Antibody Positive Myasthenia Gravis Pazienti affetti da Miastenia Grave MuSK-positiva, Patients with MuSK Antibody Positive Myasthenia Gravis Pazienti affetti da Miastenia Grave MuSK-positiva, Diseases [C] - Musculoskeletal Diseases [C05]
 
 
NCT03781479 / 2017-004600-22: Controlled Trial to Evaluate Amifampridine Phosphate in Spinal Muscular Atrophy Type 3 Patients

Completed
2
13
Europe
Amifampridine Phosphate, 3,4 diaminopyridine phosphate, Placebo Oral Tablet
Catalyst Pharmaceuticals, Inc., Catalyst Pharmaceuticals, Inc
Muscular Atrophy, Spinal
07/20
07/20
SMA3, NCT03819660: Long Term Safety of Amifampridine Phosphate in Spinal Muscular Atrophy 3

Enrolling by invitation
2
12
Europe
Amifampridine Phosphate 10 MG Oral Tablet
Catalyst Pharmaceuticals, Inc.
Muscle Atrophy
12/21
04/22
NCT05123053: Firdapse for Post-BOTOX Vocal Weakness

Recruiting
2
10
US
Amifampridine, Firdapse
Augusta University
Post-BOTOX Vocal Weakness
06/23
06/23

Download Options